HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement.

AuthorsJean Bousquet, Cezmi A Akdis, Marek Jutel, Claus Bachert, Ludger Klimek, Ioana Agache, Ignacio J Ansotegui, Anna Bedbrook, Sinthia Bosnic-Anticevich, G Walter Canonica, Tomas Chivato, Alvaro A Cruz, Wienczyslawa Czarlewski, Stefano Del Giacco, Hui Du, Joao A Fonseca, Yadong Gao, Tari Haahtela, Karin Hoffmann-Sommergruber, Juan-Carlos Ivancevich, Nikolaï Khaltaev, Edward F Knol, Piotr Kuna, Desiree Larenas-Linnemann, Joaquim Mullol, Robert Naclerio, Ken Ohta, Yoshitaka Okamoto, Liam O'Mahony, Gabrielle L Onorato, Nikos G Papadopoulos, Oliver Pfaar, Boleslaw Samolinski, Jürgen Schwarze, Sanna Toppila-Salmi, Maria-Teresa Ventura, Arunas Valiulis, Arzu Yorgancioglu, Torsten Zuberbier, Ruby Pawankar, ARIA-MASK Study Group
JournalAllergy (Allergy) Vol. 75 Issue 10 Pg. 2440-2444 (10 2020) ISSN: 1398-9995 [Electronic] Denmark
PMID32233040 (Publication Type: Letter)
Chemical References
  • Adrenal Cortex Hormones
Topics
  • Administration, Intranasal
  • Adrenal Cortex Hormones
  • COVID-19
  • Humans
  • Rhinitis, Allergic (drug therapy)
  • SARS-CoV-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: